Platelet receptors
Comment on
-
Abciximab in patients with ruptured intracranial aneurysms.AJNR Am J Neuroradiol. 2005 Aug;26(7):1744-50. AJNR Am J Neuroradiol. 2005. PMID: 16091524 Free PMC article.
References
-
- Shlansky-Goldberg S. Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries? J Vasc Interv Radiol 2002;13:229–46 - PubMed
-
- Connors JJ. Pharmacologic agents in stroke prevention, acute stroke therapy, and interventional procedures. J Vasc Interv Radiol 2004;15:S87–101 - PubMed
-
- Shlansky-Goldberg R. Platelet aggregation inhibitors for use in peripheral vascular interventions: what can we learn from the experience in the coronary arteries? J Vasc Interv Radiol 2002;13:229–46 - PubMed
-
- Moser M, Bertram U, Peter K, et al. Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. J Cardiovasc Pharmacol 2003;41:586–92 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources